GoKawiilColossal Biosciences links de-extinction tech to human health research
Colossal Biosciences CEO Ben Lamm discussed the company's efforts to revive extinct species, including dire wolves, woolly mammoths, dodos, Tasmanian tigers, and moa, at the CNBC AI Forum. Lamm described using AI models to reconstruct the dire wolf genome from ancient DNA from a skull and tooth, then editing gray wolf cells to create embryos carried by surrogate dogs, resulting in three pups named Romulus, Remus, and Khaleesi. He said the company expects to reveal more de-extinct species within the next one to two years.
GoKawiil's interpretation of the reporting above, not reported fact.
Lamm's comparison to conservation and 'general human benefit' suggests the company is positioning its genetic engineering work as having applications beyond novelty species revival, potentially including human health, though specifics of that claim weren't detailed. The continued pace of species recreation could signal growing confidence in Colossal's genome-editing pipeline as a commercially viable platform rather than a one-off experiment.
- Colossal Biosciences has produced three genetically engineered dire wolf pups using ancient DNA and gray wolf cells.
- CEO Ben Lamm says more de-extinct species, possibly including additional dire wolves, could emerge within one to two years.
- Lamm frames the work as distinct from Jurassic Park, emphasizing conservation and potential human benefits over entertainment.
Source: cnbc.com — Colleen Mckown, 2026-10-10
Published there as: “How de-extincting dire wolves and woolly mammoths may extend human life”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.